Search

everythinglearnresearchcommunity

for

Search:↓

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Spironolactone effectively treats female pattern hair loss with few side effects.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.